Advent Capital Management Pfizer Inc Transaction History

Advent Capital Management

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $2.61 Million - $3.39 Million	100,000 New	100,000 $2.88 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $4.52 Million - $5.48 Million	-150,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $4.05 Million - $5.79 Million	150,000 New	150,000 $4.9 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $2.44 Million - $3.16 Million	-75,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $924,499 - $1.04 Million	-25,000 Reduced 25.0%	75,000 $3.25 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $3.19 Million - $3.5 Million	85,000 Added 566.67%	100,000 $4.25 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $570,856 - $650,838	14,839 Added 9216.77%	15,000 $655,000
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $5,549 - $6,731	161 New	161 $7,000
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $164,899 - $175,799	-5,000 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $159,550 - $185,100	5,000 New	5,000 $177,000
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $831,500 - $882,250	-25,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $775,000 - $853,750	25,000	25,000 $893,000

3,257

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $139B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Advent Capital Management , based on Form 13F filings with the SEC.

Stay updated on Advent Capital Management with notifications on news.